LRI Investments LLC Grows Stock Holdings in Oscar Health, Inc. $OSCR

LRI Investments LLC raised its position in Oscar Health, Inc. (NYSE:OSCR) by 377.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,233 shares of the company’s stock after purchasing an additional 975 shares during the period. LRI Investments LLC’s holdings in Oscar Health were worth $26,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. CWM LLC lifted its holdings in shares of Oscar Health by 130.3% during the 2nd quarter. CWM LLC now owns 7,380 shares of the company’s stock worth $158,000 after acquiring an additional 4,176 shares during the last quarter. Udine Wealth Management Inc. purchased a new stake in Oscar Health in the second quarter worth about $1,318,000. Kingswood Wealth Advisors LLC purchased a new stake in shares of Oscar Health during the second quarter valued at approximately $576,000. KLP Kapitalforvaltning AS grew its holdings in shares of Oscar Health by 8.3% during the second quarter. KLP Kapitalforvaltning AS now owns 36,700 shares of the company’s stock valued at $787,000 after buying an additional 2,800 shares during the last quarter. Finally, Belpointe Asset Management LLC bought a new position in Oscar Health during the second quarter valued at approximately $690,000. 75.70% of the stock is owned by institutional investors.

Oscar Health Stock Performance

NYSE:OSCR opened at $20.36 on Tuesday. The company has a fifty day moving average of $17.90 and a two-hundred day moving average of $15.93. The stock has a market capitalization of $5.27 billion, a PE ratio of -25.14 and a beta of 1.89. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping analysts’ consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. During the same period in the previous year, the firm earned $0.20 earnings per share. Oscar Health’s quarterly revenue was up 29.0% compared to the same quarter last year. As a group, research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In other news, insider Mario Schlosser sold 395,000 shares of the business’s stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares in the company, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 25.11% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on OSCR shares. Barclays reduced their price objective on Oscar Health from $17.00 to $11.00 and set an “underweight” rating for the company in a research note on Wednesday, July 23rd. Robert W. Baird reissued a “neutral” rating and issued a $14.00 price objective (down from $28.00) on shares of Oscar Health in a research note on Friday, July 25th. Raymond James Financial lowered Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a research note on Saturday, August 9th. Finally, Piper Sandler reduced their price objective on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. Four investment analysts have rated the stock with a Hold rating and six have given a Sell rating to the company. According to MarketBeat, Oscar Health presently has a consensus rating of “Strong Sell” and a consensus target price of $12.64.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.